GSPT1 degrader molecular glue therapy(Degron therapeutics)

N/A

Report date: 2025/01/14 09:27:59
NME

Base Information

Drug NameGSPT1 degrader molecular glue therapy(Degron therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionEukaryotic peptide chain release factor GTP-binding subunit ERF3A degraders
TargetsEukaryotic peptide chain release factor GTP-binding subunit ERF3A
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Dage Biomedical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Dage Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A